![](https://static.wixstatic.com/media/a8e651_dfbac336d9084e799ebd4a69cbb9bd00~mv2.png/v1/fill/w_500,h_72,al_c,q_85,enc_auto/a8e651_dfbac336d9084e799ebd4a69cbb9bd00~mv2.png)
Chief Medical Officer, Dr. Aron Tendler gives exclusive commentary in Psychiatric Times, highlighting how Deep TMS provides hope for the 42%
of OCD patients who are treatment-resistant and emphasizes the success that Deep TMS has had as a non-invasive treatment.
Comments